# Kilroy Realty Corp: financial statements, quarterly

KRC · NYSE · CIK 1025996 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/krc.md) · [Financials](/companies/krc/financials.md) · [Filings](/companies/krc/filings.md) · [Insiders](/companies/krc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/krc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3.0](/filings/0001025996-24-000207.md) | [2.9](/filings/0001025996-24-000267.md) | [3.4 d](/filings/0001628280-26-007051.md) | [3.7](/filings/0001025996-25-000141.md) | [4.8](/filings/0001025996-25-000250.md) | [4.0](/filings/0001628280-25-046780.md) | [5.0 d](/filings/0001628280-26-007051.md) | [4.6](/filings/0001628280-26-028013.md) | [4.8](/filings/0001025996-25-000250.md) | [4.8](/filings/0001628280-25-046780.md) | [4.8 d](/filings/0001628280-26-007051.md) | [4.7](/filings/0001628280-26-028013.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [26.4](/filings/0001025996-23-000180.md) | [29.8](/filings/0001025996-23-000218.md) | [32.3 d](/filings/0001025996-24-000094.md) | [38.9](/filings/0001025996-24-000136.md) | [36.8](/filings/0001025996-25-000250.md) | [36.4](/filings/0001628280-25-046780.md) | [33.2 d](/filings/0001628280-26-007051.md) | [31.1](/filings/0001628280-26-028013.md) | [30.8](/filings/0001025996-25-000250.md) | [32.2](/filings/0001628280-25-046780.md) | [32.1 d](/filings/0001628280-26-007051.md) | [38.5](/filings/0001628280-26-028013.md) |
| Net income | $m | [61.3](/filings/0001025996-24-000267.md) | [58.7](/filings/0001025996-24-000267.md) | [53.0 d](/filings/0001628280-26-007051.md) | [55.7](/filings/0001628280-25-046780.md) | [54.5](/filings/0001628280-25-046780.md) | [57.7](/filings/0001628280-25-046780.md) | [65.0 d](/filings/0001628280-26-007051.md) | [43.7](/filings/0001628280-26-028013.md) | [79.6](/filings/0001628280-25-046780.md) | [162](/filings/0001628280-25-046780.md) | [17.1 d](/filings/0001628280-26-007051.md) | [(14.7)](/filings/0001628280-26-028013.md) |
| Diluted EPS | $ per share | [0.47](/filings/0001025996-24-000207.md) | [0.45](/filings/0001025996-24-000267.md) | not reported | [0.42](/filings/0001025996-25-000141.md) | [0.41](/filings/0001025996-25-000250.md) | [0.44](/filings/0001628280-25-046780.md) | not reported | [0.33](/filings/0001628280-26-028013.md) | [0.57](/filings/0001025996-25-000250.md) | [1.31](/filings/0001628280-25-046780.md) | not reported | [(0.16)](/filings/0001628280-26-028013.md) |
| Basic EPS | $ per share | [0.47](/filings/0001025996-24-000207.md) | [0.45](/filings/0001025996-24-000267.md) | not reported | [0.42](/filings/0001025996-25-000141.md) | [0.41](/filings/0001025996-25-000250.md) | [0.44](/filings/0001628280-25-046780.md) | not reported | [0.33](/filings/0001628280-26-028013.md) | [0.58](/filings/0001025996-25-000250.md) | [1.32](/filings/0001628280-25-046780.md) | not reported | [(0.16)](/filings/0001628280-26-028013.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.4](/filings/0001025996-24-000207.md) | [0.6](/filings/0001025996-24-000267.md) | [0.5](/filings/0001628280-25-046780.md) | [0.9](/filings/0001025996-25-000141.md) | [0.8](/filings/0001025996-25-000250.md) | [0.6](/filings/0001628280-25-046780.md) | [0.2](/filings/0001628280-26-007051.md) | [0.1](/filings/0001025996-25-000141.md) | [0.2](/filings/0001025996-25-000250.md) | [0.4](/filings/0001628280-25-046780.md) | [0.2](/filings/0001628280-26-028013.md) | [0.2](/filings/0001628280-26-028013.md) |
| Total assets | $bn | [10.9](/filings/0001025996-23-000180.md) | [11.5](/filings/0001025996-23-000218.md) | [11.4](/filings/0001025996-25-000052.md) | [11.6](/filings/0001025996-24-000136.md) | [11.5](/filings/0001025996-24-000207.md) | [11.4](/filings/0001025996-24-000267.md) | [10.9](/filings/0001628280-26-007051.md) | [10.9](/filings/0001025996-25-000141.md) | [10.9](/filings/0001025996-25-000250.md) | [11.0](/filings/0001628280-25-046780.md) | [10.9](/filings/0001628280-26-028013.md) | [10.8](/filings/0001628280-26-028013.md) |
| Total liabilities | $bn | [5.2](/filings/0001025996-23-000180.md) | [5.8](/filings/0001025996-23-000218.md) | [5.7](/filings/0001025996-25-000052.md) | [6.0](/filings/0001025996-24-000136.md) | [5.9](/filings/0001025996-24-000207.md) | [5.8](/filings/0001025996-24-000267.md) | [5.3](/filings/0001628280-26-007051.md) | [5.3](/filings/0001025996-25-000141.md) | [5.3](/filings/0001025996-25-000250.md) | [5.3](/filings/0001628280-25-046780.md) | [5.3](/filings/0001628280-26-028013.md) | [5.3](/filings/0001628280-26-028013.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [5.4](/filings/0001025996-23-000180.md) | [5.4](/filings/0001025996-23-000218.md) | [5.4](/filings/0001025996-25-000052.md) | [5.4](/filings/0001025996-24-000136.md) | [5.4](/filings/0001025996-24-000207.md) | [5.4](/filings/0001025996-24-000267.md) | [5.4](/filings/0001628280-26-007051.md) | [5.4](/filings/0001025996-25-000141.md) | [5.4](/filings/0001025996-25-000250.md) | [5.5](/filings/0001628280-25-046780.md) | [5.4](/filings/0001628280-26-028013.md) | [5.3](/filings/0001628280-26-028013.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [101 d](/filings/0001025996-24-000207.md) | [209 d](/filings/0001025996-24-000267.md) | [110 d](/filings/0001628280-26-007051.md) | [168](/filings/0001025996-25-000141.md) | [88.7 d](/filings/0001025996-25-000250.md) | [176 d](/filings/0001628280-25-046780.md) | [108 d](/filings/0001628280-26-007051.md) | [137](/filings/0001628280-26-028013.md) | [144 d](/filings/0001025996-25-000250.md) | [177 d](/filings/0001628280-25-046780.md) | [109 d](/filings/0001628280-26-007051.md) | [151](/filings/0001628280-26-028013.md) |
| Dividends paid | $m | [63.9 d](/filings/0001025996-24-000207.md) | [63.9 d](/filings/0001025996-24-000267.md) | [63.9 d](/filings/0001628280-26-007051.md) | [63.9](/filings/0001025996-25-000141.md) | [64.0 d](/filings/0001025996-25-000250.md) | [64.0 d](/filings/0001628280-25-046780.md) | [64.4 d](/filings/0001628280-26-007051.md) | [64.4](/filings/0001628280-26-028013.md) | [64.5 d](/filings/0001025996-25-000250.md) | [64.5 d](/filings/0001628280-25-046780.md) | [64.5 d](/filings/0001628280-26-007051.md) | [64.5](/filings/0001628280-26-028013.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-028013.md) | not reported | not reported | not reported | [72.7](/filings/0001628280-26-028013.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [117](/filings/0001025996-23-000180.md) | [117](/filings/0001025996-23-000218.md) | [117](/filings/0001025996-24-000136.md) | [117](/filings/0001025996-24-000207.md) | [117](/filings/0001025996-24-000267.md) | [118](/filings/0001025996-25-000141.md) | [118](/filings/0001025996-25-000250.md) | [118](/filings/0001628280-25-046780.md) | [119](/filings/0001628280-26-028013.md) | [119](/filings/0001025996-25-000250.md) | [119](/filings/0001628280-25-046780.md) | [118](/filings/0001628280-26-028013.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 116,278,807 at 2026-04-23, from the cover of the [10-Q filed 2026-04-28](/filings/0001628280-26-028013.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.